Growth Metrics

Innoviva (INVA) Revenue (2016 - 2025)

Historic Revenue for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $107.8 million.

  • Innoviva's Revenue rose 2043.62% to $107.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.8 million, marking a year-over-year increase of 933.25%. This contributed to the annual value of $358.7 million for FY2024, which is 1554.07% up from last year.
  • Latest data reveals that Innoviva reported Revenue of $107.8 million as of Q3 2025, which was up 2043.62% from $100.3 million recorded in Q2 2025.
  • Over the past 5 years, Innoviva's Revenue peaked at $107.8 million during Q3 2025, and registered a low of $491000.0 during Q1 2025.
  • For the 5-year period, Innoviva's Revenue averaged around $33.9 million, with its median value being $1.2 million (2022).
  • As far as peak fluctuations go, Innoviva's Revenue tumbled by 9864.51% in 2021, and later surged by 1009367.35% in 2024.
  • Over the past 5 years, Innoviva's Revenue (Quarter) stood at $989000.0 in 2021, then rose by 6.27% to $1.1 million in 2022, then surged by 45.39% to $1.5 million in 2023, then fell by 19.18% to $1.2 million in 2024, then soared by 8628.74% to $107.8 million in 2025.
  • Its Revenue stands at $107.8 million for Q3 2025, versus $100.3 million for Q2 2025 and $491000.0 for Q1 2025.